DekaBank Deutsche Girozentrale
IRWD icon

DekaBank Deutsche Girozentrale’s Ironwood Pharmaceuticals IRWD Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-134,500
Closed -$1.38M – 1062
2020
Q1 		$1.38M Sell
134,500
-28,800
-18% -$339K 0.01% 522
2019
Q4 		$2.25M Hold
163,300
– – 0.01% 491
2019
Q3 		$1.4M Hold
163,300
– – 0.01% 597
2019
Q2 		$1.76M Buy
163,300
+135,889
+496% +$1.52M 0.01% 657
2019
Q1 		$440K Sell
27,411
-79,484
-74% -$888K ﹤0.01% 928
2018
Q4 		$879K Buy
106,895
+79,484
+290% +$912K 0.01% 713
2018
Q3 		$440K Buy
27,411
+3,710
+16% +$58.6K ﹤0.01% 949
2018
Q2 		$376K Sell
23,701
-47,760
-67% -$707K ﹤0.01% 968
2018
Q1 		$910K Buy
71,461
+1,134
+2% +$14.1K 0.01% 739
2017
Q4 		$879K Hold
70,327
– – 0.01% 719
2017
Q3 		$879K Hold
70,327
– – 0.01% 727
2017
Q2 		$1.08M Hold
70,327
– – 0.01% 672
2017
Q1 		$1.05M Sell
70,327
-5,970
-8% -$81.6K 0.01% 608
2016
Q4 		$972K Buy
76,297
+5,732
+8% +$72.4K 0.01% 547
2016
Q3 		$910K Hold
70,565
– – 0.01% 559
2016
Q2 		$767K Buy
70,565
+5,373
+8% +$52.5K 0.01% 587
2016
Q1 		$572K Sell
65,192
-11,702
-15% -$96.5K 0.01% 632
2015
Q4 		$763K Buy
76,894
+1,433
+2% +$13.8K 0.01% 609
2015
Q3 		$659K Buy
75,461
+2,627
+4% +$24.5K 0.01% 625
2015
Q2 		$736K Buy
72,834
+2,746
+4% +$31.9K 0.01% 619
2015
Q1 		$939K Sell
70,088
-7,283
-9% -$95.6K 0.01% 582
2014
Q4 		$976K Sell
77,371
-6,925
-8% -$79.3K 0.01% 564
2014
Q3 		$915K Buy
84,296
+2,507
+3% +$28.7K 0.01% 529
2014
Q2 		$1.05M Sell
81,789
-4,657
-5% -$50.6K 0.02% 491
2014
Q1 		$892K Buy
86,446
+21,492
+33% +$242K 0.01% 487
2013
Q4 		$650K Buy
64,954
+2,985
+5% +$26.8K 0.01% 512
2013
Q3 		$615K Buy
+61,969
New +$608K 0.01% 521

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

DekaBank Deutsche Girozentrale's IRWD Position: Q2 2020 in Review

DekaBank Deutsche Girozentrale sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2020, closing a stake of 134,500 shares — an estimated $1.38M sold.

DekaBank Deutsche Girozentrale first reported a position in IRWD in Q3 2013 and held it in 27 quarters. The position peaked at $2.25M in Q4 2019. 202 funds tracked by Wall St. Rank hold IRWD as of Q2 2020.

  • DekaBank Deutsche Girozentrale reported no remaining Ironwood Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 134,500 Ironwood Pharmaceuticals shares in Q2 2020, an estimated $1.38M.
  • DekaBank Deutsche Girozentrale first reported a position in Ironwood Pharmaceuticals in Q3 2013 and held it in 27 quarters.
  • DekaBank Deutsche Girozentrale's Ironwood Pharmaceuticals position peaked at $2.25M in Q4 2019.
  • 202 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2020.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2020, filed 4 Aug 2020.